Paul Tudor Jones II's position in MapLight Therapeutics is currently worth $1.06M. That's 0.01% of their equity portfolio (1206th largest holding). The investor owns 4.65% of the outstanding MapLight Therapeutics stock. Paul Tudor Jones II started to build up the position in MapLight Therapeutics in Q4 2025. Since then they sold 11.1k shares.